Substrate envelope based design of new HIV-1 protease inhibitors active against drug-resistant HIV-1

被引：0
|
作者：
Ali, Akbar [1 ]
Reddy, G. S. Kiran Kumar [1 ]
Nalam, Madhavi N. L.
Anjum, Saima G. [1 ]
Cao, Hong [1 ]
Altman, Michael D. [1 ,2 ,3 ]
Tidor, Bruce [4 ,5 ]
Rana, Tariq M. [1 ]
Schiffer, Celia A.
机构：
[1] Univ Massachusetts, Sch Med, Chem Biol Program, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA
[2] MIT, Dept Chem & Comp Sci, Cambridge, MA 02139 USA
[3] MIT, Artificial Intelligence Lab, Cambridge, MA 02139 USA
[4] MIT, Biol Engn Div, Cambridge, MA 02139 USA
[5] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2009年 / 238卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
102-MEDI
引用
收藏
页数：1
相关论文
共 50 条
  • [1] HIV-1 protease inhibitors from inverse design in the substrate envelope exhibit subnanomolar binding to drug-resistant variants
    Altman, Michael D.
    Ali, Akbar
    Reddy, G. S. Kiran Kumar
    Nalam, Madhavi N. L.
    Anjum, Saima Ghafoor
    Cao, Hong
    Chellappan, Sripriya
    Kairys, Visvalclas
    Fernandes, Miguel X.
    Gilson, Michael K.
    Schiffer, Celia A.
    Rana, Tariq M.
    Tidor, Bruce
    [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2008, 130 (19) : 6099 - 6113
  • [2] HIV-1 Integrase Inhibitors That Are Active against Drug-Resistant Integrase Mutants
    Smith, Steven J.
    Zhao, Xue Zhi
    Passos, Dario Oliveira
    Lyumkis, Dmitry
    Burke, Terrence R., Jr.
    Hughes, Stephen H.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2020, 64 (09)
  • [3] Substrate envelope based design of potent HIV-1 protease inhibitors resilient to resistance
    Nalam, M. N. L.
    Ali, A.
    Reddy, G. S. K. K.
    Anjum, S. G.
    Rana, T. M.
    Schiffer, C. A.
    [J]. ANTIVIRAL THERAPY, 2010, 15 : A15 - A15
  • [4] Evaluation of the substrate envelope hypothesis for inhibitors of HIV-1 protease
    Chellappan, Sripriya
    Kairys, Visvaldas
    Fernandes, Miguel X.
    Schiffer, Celia
    Gilson, Michael K.
    [J]. PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 2007, 68 (02) : 561 - 567
  • [5] Computational drug design of new HIV-1 protease inhibitors
    Lebon, F
    Vinals, C
    Feytmans, E
    Durant, F
    [J]. ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY, 1996, 104 (03) : B44 - B44
  • [6] Darunavir, a conceptually new HIV-1 protease inhibitor for the treatment of drug-resistant HIV
    Ghosh, Arun K.
    Dawson, Zachary L.
    Mitsuya, Hiroaki
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2007, 15 (24) : 7576 - 7580
  • [7] Screening Novel HIV-1 Protease Inhibitors Based on the Substrate Envelope Hypothesis
    Miao Youpan
    Li Aixiu
    Liu Tao
    Wu Kezhu
    Ma Yi
    [J]. ACTA CHIMICA SINICA, 2009, 67 (10) : 1098 - 1102
  • [8] Structure-Based Identification of HIV-1 Nucleocapsid Protein Inhibitors Active against Wild-Type and Drug-Resistant HIV-1 Strains
    Mori, Mattia
    Kovalenko, Lesia
    Malancona, Savina
    Saladini, Francesco
    De Forni, Davide
    Pires, Manuel
    Humbert, Nicolas
    Real, Eleonore
    Botzanowski, Thomas
    Cianferani, Sarah
    Giannini, Alessia
    Dasso Lang, Maria Chiara
    Cugia, Giulia
    Poddesu, Barbara
    Lori, Franco
    Zazzi, Maurizio
    Harper, Steven
    Summa, Vincenzo
    Mely, Yves
    Botta, Maurizio
    [J]. ACS CHEMICAL BIOLOGY, 2018, 13 (01) : 253 - 266
  • [9] APHS can act synergically with clinically available HIV-1 reverse transcriptase and protease inhibitors and is active against several drug-resistant HIV-1 strains in vitro
    Pereira, CF
    Paridaen, JTML
    van de Bovenkamp, M
    Middel, J
    Verhoef, J
    Nottet, HSLM
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 51 (05) : 1181 - 1189
  • [10] Drug design: New inhibitors for HIV-1 protease based on Nelfinavir as lead
    Perez, M. A. S.
    Fernandes, P. A.
    Ramos, M. J.
    [J]. JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2007, 26 (03): : 634 - 642
12345